author-photo

Revathi Kollipara

Rush University Medical Center

9

Papers

22

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

The May-Hegglin anomaly: a rare cause of a common complaint

2021 Case Reports
Show All
- Source
- Cite
- Save
Citations (0)
Associations between longitudinal pretreatment BMI and neutrophil/lymphocyte ratio(NLR) and progression-free(PFS) and overall survival(OS) in advanced NSCLC patients treated with single agent anti-PD-1/anti-PDL1 monoclonal antibodies(mAbs).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (20)
Decreasing BMI/weight immediately prior to starting anti-PD-1/PDL-1 monoclonal antibodies for treatment for stage IV non-small cell lung cancer is associated with shorter progression-free survival.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P1.05 Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on ANTI-PD-1 Therapy

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Timed sequential therapy with high-dose cytarabine and mitoxantrone as an induction regimen for acute myeloid leukemia: An update on adverse events.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 404: Prognostic value of soluble and cell surface immune-checkpoint molecules in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-1/-L1 immunotherapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)